PXL770
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PXL770, covering 2021-10-28 to 2024-12-16. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess PXL770 in Subjects With Adrenomyeloneuropathy (AMN) Form of X-linked Adrenoleukodystrophy (X-ALD or ALD) [Phase 2]